Delivery Order SPE2DR25D1004-SPE2DR26FSZE9

The Defense Logistics Agency issued a $12,203.44 delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Xhance 93 mcg nasal spray (16 mL). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is February 9, 2026. The...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,134.11 to supply Xhance 93 MCG nasal spray (16 mL units) with an ultimate completion date of September 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and was awarded on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger indefinite delivery contract...

The Defense Logistics Agency awarded a delivery order valued at $1,266.79 to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16ml) on December 4, 2025, with completion scheduled for December 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...

The Defense Logistics Agency awarded a $16,843.25 delivery order to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16 mL) on December 5, 2025, with an ultimate completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order will be performed at AmerisourceBergen's corporate...

The Defense Logistics Agency awarded a $11,725.96 delivery order to AmerisourceBergen Drug Corp for XHANCE 93 MCG nasal spray (16 mL) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Xhance 93 microgram nasal spray in 16-milliliter units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing with a ceiling value of $3,180.19 and an ultimate completion date of August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...

The Defense Logistics Agency awarded a delivery order valued at $4,668.46 to AmerisourceBergen Drug Corp for XHANCE 93 MCG Nasal Spray (16ML) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical supplier within the federal medical...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for Xhance 93 micrograms nasal spray (16 milliliters) with a ceiling value of $3,221.73. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 5, 2025, and performance at the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...

The Defense Logistics Agency awarded a delivery order valued at $2,377.77 to AmerisourceBergen Drug Corp for Xhance 93 microgram nasal spray (16 milliliters) on January 20, 2026, with an ultimate completion date of January 21, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...

The Defense Logistics Agency awarded a $4,547.56 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Xhance 93 microgram nasal spray (16 milliliters). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...